Altimmune (ALT) Consolidated Net Income (2016 - 2025)
Historic Consolidated Net Income for Altimmune (ALT) over the last 17 years, with Q3 2025 value amounting to -$19.0 million.
- Altimmune's Consolidated Net Income rose 1676.95% to -$19.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$84.0 million, marking a year-over-year increase of 1882.44%. This contributed to the annual value of -$95.1 million for FY2024, which is 752.99% down from last year.
- Altimmune's Consolidated Net Income amounted to -$19.0 million in Q3 2025, which was up 1676.95% from -$22.1 million recorded in Q2 2025.
- Altimmune's Consolidated Net Income's 5-year high stood at -$14.9 million during Q1 2021, with a 5-year trough of -$33.5 million in Q3 2021.
- In the last 5 years, Altimmune's Consolidated Net Income had a median value of -$22.1 million in 2025 and averaged -$22.4 million.
- As far as peak fluctuations go, Altimmune's Consolidated Net Income crashed by 28253.86% in 2021, and later skyrocketed by 2983.29% in 2022.
- Over the past 5 years, Altimmune's Consolidated Net Income (Quarter) stood at -$23.9 million in 2021, then rose by 9.33% to -$21.7 million in 2022, then plummeted by 46.08% to -$31.6 million in 2023, then grew by 26.37% to -$23.3 million in 2024, then increased by 18.39% to -$19.0 million in 2025.
- Its Consolidated Net Income was -$19.0 million in Q3 2025, compared to -$22.1 million in Q2 2025 and -$19.6 million in Q1 2025.